4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Cizzle Biotechnology Holdings Plc (CIZ) operates in the Biotechnology industry and is headquartered in London, United Kingdom with about 5 employees. Its market capitalization is roughly £7 million. In the fiscal year ended 2025-12-31, CIZ reported £0M in revenue and (£1M) in net income.
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood immunoassay test for early lung cancer detection using CIZ1B biomarker technology.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | £0M | £0M | £0M | £0M | — |
| Gross Profit | — | — | — | £0M | £0M |
| Operating Income (EBIT) | (£1M) | (£1M) | (£1M) | (£1M) | — |
| Net Income | (£1M) | (£2M) | (£2M) | (£1M) | — |
GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | £0M | £0M | £2M | £3M | — |
| Total Liabilities | £1M | £0M | £0M | £0M | — |
GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CIZ viewer.
About TickerBase · Data methodology & sources · Privacy · Terms